
Barbara A. Murphy, M.D.
- Professor of Medicine (Hematology/Oncology)
- Director, Head & Neck Oncology
- Program Director, Pain & Symptom Management Program
Phone
777 Preston Research Building
Nashville, TN 37232-6307
Barbara A. Murphy, M.D.
- Professor of Medicine (Hematology/Oncology)
- Director, Head & Neck Oncology
- Program Director, Pain & Symptom Management Program
615-343-4677
barbara.murphy@vumc.org
777 Preston Research Building
Nashville, TN 37232-6307
Research Program
Departments/Affiliations
Provider Information
Profile
Dr. Murphy is a medical oncologist who specializes in head and neck cancer as well as in pain and symptom management control. The Head and Neck Oncology Program has achieved national recognition for its expertise in combined modality therapy. Her clinical interests for head and neck cancer include identifying new and more effective treatments. For example, Dr. Murphy studies patients who have been diagnosed with head and neck cancer that has either spread throughout the body (metastasized) or has returned after initial treatment with surgery or radiation (recurred). Although several chemotherapy drugs (anti-cancer medications) are effective in the treatment of metastatic or recurrent head and neck cancer, these agents are unable to provide a cure and are associated with side effects.
Dr. Murphy recently developed a new Pain & Symptom Management Program dedicated to providing our patients with a comprehensive and integrative approach to their health care. Dr. Murphy works with a multidisciplinary team of health care professionals to address specific problems facing cancer patients and their families and to ensure a coordinated plan of care. The program is committed to improving the quality of life of patients and families by helping to identify and resolve physical, emotional and spiritual issues.
Education
- Duke University, B.S., Zoology, 1983
- Bowman-Gray School of Medicine, M.D., 1987
- Internal Medicine Residency,Greenwich Hospital (Yale affiliated), 1987-1990
- Fellow in Medical Oncology, Memorial Sloan-Kettering Cancer Center, 1990-1993
- Chief Fellow, Memorial Sloan-Kettering Cancer Center, 1991-1992
- Research Fellow, Memorial Sloan-Kettering Cancer Center, 1992-1993
Research Emphasis
Pain, Symptom Management, head, neck, cancer
Research Description
. . .
Publications
- Ganzer H, Rothpletz-Puglia P, Byham-Gray L, Murphy BA, Touger-Decker R. The eating experience in long-term survivors of head and neck cancer: a mixed-methods study. Support Care Cancer [print-electronic]. 2015 Nov; 23(11): 3257-68. PMID: 25851804, PII: 10.1007/s00520-015-2730-9, DOI: 10.1007/s00520-015-2730-9, ISSN: 1433-7339.
- Deng J, Ridner SH, Aulino JM, Murphy BA. Assessment and measurement of head and neck lymphedema: state-of-the-science and future directions. Oral Oncol [print-electronic]. 2015 May; 51(5): 431-7. PMID: 25703799, PII: S1368-8375(15)00006-8, DOI: 10.1016/j.oraloncology.2015.01.005, ISSN: 1879-0593.
- Jackson LK, Deng J, Ridner SH, Gilbert J, Dietrich MS, Murphy BA. Preliminary Testing of a Patient-Reported Outcome Measure for Recurrent or Metastatic Head and Neck Cancer. Am J Hosp Palliat Care [print-electronic]. 2015 Feb 2/8/2015; PMID: 25667146, PII: 1049909115569591, DOI: 10.1177/1049909115569591, ISSN: 1938-2715.
- Deng J, Ridner SH, Wells N, Dietrich MS, Murphy BA. Development and preliminary testing of head and neck cancer related external lymphedema and fibrosis assessment criteria. Eur J Oncol Nurs [print-electronic]. 2015 Feb; 19(1): 75-80. PMID: 25190635, PII: S1462-3889(14)00102-1, DOI: 10.1016/j.ejon.2014.07.006, ISSN: 1532-2122.
- Jackson LK, Johnson DB, Sosman JA, Murphy BA, Epstein JB. Oral health in oncology: impact of immunotherapy. Support Care Cancer [print-electronic]. 2015 Jan; 23(1): 1-3. PMID: 25216852, DOI: 10.1007/s00520-014-2434-6, ISSN: 1433-7339.
- Chung CH, Lee JW, Slebos RJ, Howard JD, Perez J, Kang H, Fertig EJ, Considine M, Gilbert J, Murphy BA, Nallur S, Paranjape T, Jordan RC, Garcia J, Burtness B, Forastiere AA, Weidhaas JB. A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Ann. Oncol [print-electronic]. 2014 Nov; 25(11): 2230-6. PMID: 25081901, PMCID: PMC4207729, PII: mdu367, DOI: 10.1093/annonc/mdu367, ISSN: 1569-8041.
- Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB, Bruner DW, Movsas B. Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. J. Natl. Cancer Inst [electronic-print]. 2014 Jul; 106(7): PMID: 25006189, PMCID: PMC4192043, PII: dju127, DOI: 10.1093/jnci/dju127, ISSN: 1460-2105.
- Johnson DB, Dahlman KH, Knol J, Gilbert J, Puzanov I, Means-Powell J, Balko JM, Lovly CM, Murphy BA, Goff LW, Abramson VG, Crispens MA, Mayer IA, Berlin JD, Horn L, Keedy VL, Reddy NM, Arteaga CL, Sosman JA, Pao W. Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. Oncologist [print-electronic]. 2014 Jun; 19(6): 616-22. PMID: 24797823, PMCID: PMC4041676, PII: theoncologist.2014-0011, DOI: 10.1634/theoncologist.2014-0011, ISSN: 1549-490X.
- Bond SM, Hawkins DK, Murphy BA. Caregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot study. Cancer Nurs. 2014 May; 37(3): 227-35. PMID: 23619332, PMCID: PMC4304699, DOI: 10.1097/NCC.0b013e31829194a3, ISSN: 1538-9804.
- Kolnick L, Deng J, Epstein JB, Migliorati CA, Rezk J, Dietrich MS, Murphy BA. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment. Oral Oncol [print-electronic]. 2014 Feb; 50(2): 135-40. PMID: 24239279, PII: S1368-8375(13)00740-9, DOI: 10.1016/j.oraloncology.2013.10.019, ISSN: 1879-0593.